A double-blind randomized clinical trial of Dracocephalum kotschyi Boiss. in the patients with diarrhea-predominant irritable bowel syndrome

Parisa Heydari , Mustafa Ghanadian, Gholamreza Asghari, Maryam Azimi, Mahmoud Babaeian, Peyman Adibi


Background and purpose: Irritable bowel syndrome (IBS) is a disease that shows its impacts on many populations worldwide. It is known as a functional disorder of the gastrointestinal tract followed by diarrhea and fecal inconsistency. Due to the lack of treatment in the allopathic medicine system for IBS, people in the western world use different herbs as alternative medicine. In the present study, we evaluated the dried extract of Dracocephalum kotschyi against IBS.

Experimental approach: In a randomized, double-blinded, placebo-controlled clinical trial, 76 diarrhea-predominant IBS patients were randomly assigned to two equal groups: the control group (given the placebo capsule containing 250 mg of dibasic calcium phosphate) and the treatment groups (given the capsule containing 75 mg of the dry extract of D. kotschyi and 175 mg of dibasic calcium phosphate as filler). The study was conducted based on Rome III criteria. We studied symptoms included in Rome III criteria and divided the study into the duration of drug administration and four weeks after drug administration. These groups were compared with those of the control group.

Findings/Results: Significant improvements were found in the quality of life, temperament, and IBS symptoms throughout the treatment duration. Quality of life, temperature, and IBS symptoms were slightly decreased in the treatment group 4 weeks after stopping the treatment. While concluding the study, we found D. kotschyi effective against IBS.

Conclusion and implications: Whole extract of D. kotschyi modulated symptoms of IBS patients and improved their quality of life.


Diarrhea; Dracocephalum kotschyi; Irritable bowel syndrome; Persian medicine; Randomized controlled trial; ROME criteria.

Full Text:



Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;150:1393-1407.DOI: 10.1053/j.gastro.2016.02.031.

Lacy BE, Patel NK. Rome criteria and a diagnostic approach of irritable bowel syndrome. J Clin Med. 2017;6(11):99.DOI: 10.3390/jcm6110099.

Hammerle CW, Surawicz CM. Updates on treatment of irritable bowel syndrome. World J Gastroenterol. 2008;14:2639-2649.DOI: 10.3748/wjg.14.2639.

Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-958.DOI: 10.1001/jama.2015.0954.

Guo R, Canter PH, Ernst E. A systematic review of randomised clinical trials of individualised herbal medicine in any indication. Postgrad Med J. 2007;83(984):633-637.DOI: 10.1136/pgmj.2007.060202.

Chang FY, Lu CL. Treatment of irritable bowel syndrome using complementary and alternative medicine. J Chin Med Assoc. 2009;72(6):294-300.DOI: 10.1016/S1726-4901(09)70375-2.

Rechinger KH, Labiatae. In: K.H. Rechinger, editors. Flora Iranica, Academische Druck-U. Verlagsantalt, Graze, Vol. 150; 1982. pp. 218-231.

Kamali M, Khosroyar S, and Mohammadi A. Antibacterial activity of various extracts from Dracocephalum kotschyi against food pathogenic microorganisms. Int J Pharmtech Res. 2015;8(9):158-163.

Mashak B, Hoseinzadeh M, Ehsanpour A, Ghanbaran AR, Vakili M. Evaluation of treatment response and side effects of spinal-Z in patients with metastatic gastroesophageal adenocarcinoma: a double-blind randomized controlled trial. Jundishapur J Chronic Dis Care. 2017;6(3): e57870.DOI:10.5812/jjcdc.57870.

Sadraei H, Asghari G, Kasiri F. Antispasmodic effect of Dracocephalum kotschyi hydroalcoholic extract on rat ileum contraction. Res Pharm Sci. 2015;10(5):446-452.PMID: 26752993.

Heydari P, Yavari M, Adibi P, Asghari G, Ghanadian SM, Dida GO, et al. Medicinal properties and active constituents of Dracocephalumkotschyi and its significance in Iran: a systematic review. Evid Based Complement Alternat Med. 20192019:1-15.DOI: 10.1155/2019/9465309.

Sadraei H, Asghari G, Shahverdi F. Antidiarrhoeal assessment of hydroalcoholic and hexane extracts of Dracocephalum kotschyi Boiss. and apigenin in mice. Res Pharm Sci. 2016;11(3):200-209.PMID: 27499789.

Sadraei H, Asghari G, Khanabadi M, Minaiyan M. Anti-inflammatory effect of apigenin and hydroalcoholic extract of Dracocephalum kotschyi on acetic acid-induced colitis in rats. Res Pharm Sci. 2017;12(4):322-329. DOI: 10.4103/1735-5362.212050.

Luo C, Zou L, Sun H, Peng J, Gao C, Bao L, et al. A review of the anti-inflammatory effects of rosmarinic acid on inflammatory diseases. Front Pharmacol. 2020;11:153.DOI: 10.3389/fphar.2020.00153.

Vafadar F, Amooaghaie R, Ehsanzadeh P, Ghanadian M, Talebi M, Ghanati F. Melatonin and calcium modulate the production of rosmarinic acid, luteolin, and apigenin in Dracocephalum kotschyi under salinity stress. Phytochemistry. 2020;177:112422.DOI: 10.1016/j.phytochem.2020.112422.

Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95(4):999-1007. DOI: 10.1111/j.1572-0241.2000.01941.x.

Masaeli N, Kheirabadi GR, Afshar H, Daghaghzadeh H, Maracy MR, Assadolahi F, et al. Validity, reliability, and factor analysis of Persian version of quality of life questionnaire for irritable bowel syndrome (IBS-QOL-34). J Res Med Sci. 2013;18(6):492-496.PMID: 24250698.

Roudsari NM, Lashgari NA, Momtaz S, Farzaei MH, Marques AM, Abdolghaffari AH. Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review. Daru. 2019;27(2):755-780. DOI: 10.1007/s40199-019-00284-1. .

Chey WD, Maneerattaporn M, Saad R. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver. 2011;5(3):253-266.DOI: 10.5009/gnl.2011.5.3.253.

Bundy R, Walker AF, Middleton RW, Marakis G, Booth JC. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement Med. 2004;10(4):667-669.DOI: 10.1089/acm.2004.10.667.

Ramarao P, Bhargava HN. Antagonism of the acute pharmacological actions of morphine by Panax ginseng extract. Gen Pharmacol. 1990; 21(6):877-880.DOI: 10.1016/0306-3623(90)90448-u.

Ahluwalia B, Mangnusson MK, Bohn L, Storsrud S, Larsson F, Savolainen O, et al. Randomized clinical trial: effects of Aloe barbadensis Mill. Extract on symptoms, fecal microbiota and fecalmetaboliteprofiles in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2020;32(8):e13860,1-13.DOI: 10.1111/nmo.13860. Epub 2020 Apr 20.

Agah S, Taleb AM, Moeini R, Gorji N, Nikbakh H. Cumin extract for symptom control in patients with irritable bowel syndrome: a case series. Middle East J Dig Dis. 2013;5(4):217-222.PMID: 24829694.

Bordbar G, Miri MB, Omidi M, Shoja S, Akhavan H. Efficacy and safety of a novel herbal medicine in the treatment of irritable bowel syndrome: a randomized double-blinded clinical trial. Gastroenterol Res Pract. 2020;2020:8213082.DOI: 10.1155/2020/8213082.

Mozaffari S, Esmaily S, Rahimi R, Baeeri M, Sanie Y, et al. Effects of Hypericum perforatum extract on rat irritsble bowel syndrome. Pharmacogn Mag. 2011;7(27):213-223.DOI: 10.4103/0973-1296.84235.

Mahboubi M. Therapeutic potential of Zataria multiflora Boiss in treatment of irritable bowel syndrome (IBS). J Diet Suppl. 2019;16(1):119-128.DOI: 10.1080/19390211.2017.1409852.

Stevenson C, Blaauw R, Fredericks E, Nutrition JVM, Roux S. Randomized clinical trial: Effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Nutrition. 2014;30(10):1151-1157.DOI: 10.1016/j.nut.2014.02.010.

Hutchings HA, Wareham K, Baxter JN, Atherton P, Kingham JG, Duane P, Thomas L, Thomas M, Ch'ng CL, Williams JG. A Randomised, cross-over, placebo-controlled study of Aloe vera in patients with irritable bowel syndrome: effects on patient quality of life. ISRN Gastroenterol. 2011;2011:206103. DOI: 10.5402/2011/206103.

Ko S, Han G, Kim S, Seo J, Chung S, Ryu B, et al. Effect of Korean herbal medicine combined with a probiotic mixture on diarrhea-dominant irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Evid Based Complement Alternat Med. 2013;2013:824605. DOI: 10.1155/2013/824605.

Rahimi R, Abdollahi M. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. World J Gastroenterol. 2012;18(7):589-600. DOI: 10.3748/wjg. v18.i7.589.

Aller R, de Lius DA, Izaola O, la Calle F, OlmoLd, Fernandez L, et al. Effect of high-fiber diet on symptoms of irritable bowel syndrome: a randomized clinical trial. Nutrition.2004; 20(9):735-737.DOI: 10.1016/j.nut.2004.05.016.

Daley A, Grimmett C, Roberts L, Wison S, Fatek M, Roalfe A, et al. The effects of exercise upon symptoms and quality of life in patients diagnosed with irritable bowel syndrome: a randomized controlled trial. Int J Sports Med. 2008; 29(9):778-782.DOI: 10.1055/s-2008-1038600.

Lin L, Chang L. Benefits and pitfalls of change from Rome III to Rome IV criteria for irritable bowel syndrome and fecal incontinence. Clin Gastroenterol Hepatol.2020;18(2):297-299.DOI: 10.1016/j.cgh.2019.10.004.


  • There are currently no refbacks.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.